Masahide Mori - Department of Thoracic Oncology, National Hospital Organization Osaka Toneyama Medical Center

基本信息

浏览量：66

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 156 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Impact of Serum Eicosapentaenoic Acid/arachidonic Acid Ratio on Overall Survival in Lung Cancer Patients Treated with Pembrolizumab: a Pilot Study

Ikue Tanaka,Yukihiro Yano,Masahide Mori,Satoru Manabe,Keisuke Fukuo

Scientific Reportsno. 1 (2024)

引用0浏览0WOSNATURE引用

Mechanisms of Resistance and Correlation Between Pre-Treatment Co-Alterations and P-Prognosis to Osimertinib in Chemo-Naïve Advanced Non-Small Cell Lung Cancer

Akihiro Tamiya,Mitsuo Osuga,Daijiro Harada,Shun-ichi Isa,Yoshihiko Taniguchi,Keiichi Nakamura,Yasuyuki Mizumori, Tsutomu Shinohara,Hidetoshi Yanai,Katsumi Nakatomi,Masahide Oki,Masahide Mori,Tomohito Kuwako,Koji Yamazaki,Atsuhisa Tamura,Masahiko Ando,Yasuhiro Koh

LUNG CANCER (2024)

引用0浏览0WOS引用

Baseline Genetic Abnormalities and Effectiveness of Osimertinib Treatment in Patients with Chemotherapy-Naïve EGFR-mutated NSCLC Based on Performance Status

Yoshihiko Taniguchi,Akihiro Tamiya,Mitsuo Osuga,Daijiro Harada,Shun-ichi Isa, Keiichi Nakamura,Yasuyuki Mizumori, Tsutomu Shinohara,Hidetoshi Yanai,Katsumi Nakatomi,Masahide Oki,Masahide Mori,Tomohito Kuwako,Koji Yamazaki,Atsuhisa Tamura,Masahiko Ando,Yasuhiro Koh

BMC Pulmonary Medicineno. 1 (2024): 1-6

引用0浏览0WOS引用

CD98 Heavy Chain Protein is Overexpressed in Non-Small Cell Lung Cancer and is a Potential Target for CAR T-cell Therapy

Moto Yaga,Kana Hasegawa,Shunya Ikeda, Miwa Matsubara,Takashi Hiroshima,Toru Kimura,Yuya Shirai,Wibowo Tansri, Hirofumi Uehara, Mana Tachikawa, Yuzuru Okairi, Masayuki Sone, Hiromi Mori, Yosuke Kogue,Hiroki Akamine,Daisuke Okuzaki,Kotaro Kawagishi, Satoshi Kawanaka, Hiroyuki Yamato, Yukiyasu Takeuchi,Eiji Okura,Ryu Kanzaki,Jiro Okami,Itsuko Nakamichi,Shigeru Nakane, Aki Kobayashi,Takashi Iwazawa,Toshiteru Tokunaga,Hideoki Yokouchi,Yukihiro Yano,Junji Uchida,Masahide Mori,Kiyoshi Komuta,Tetsuro Tachi,Hideki Kuroda,Noriyuki Kijima,Haruhiko Kishima,Michiko Ichii,Shinji Futami,Yujiro Naito,Takayuki Shiroyama,Kotaro Miyake,Shohei Koyama,Haruhiko Hirata,Yoshito Takeda,Soichiro Funaki,Yasushi Shintani,Atsushi Kumanogoh,Naoki Hosen

SCIENTIFIC REPORTSno. 1 (2024)

引用0浏览0WOS引用

Abstract 964: Updated results of a prospective observational multicenter study on resistance mechanisms to osimertinib using circulating tumor DNA analyses in EGFR-mutated non-small cell lung cancer patients (ELUCIDATOR study)

Mitsuo Osuga,Akihiro Tamiya,Daijiro Harada,Yasuyuki Mizumori,Shun-ichi Isa,Yoshihiko Taniguchi, Keiichi Nakamura, Tsutomu Shinohara,Hidetoshi Yanai,Katsumi Nakatomi,Masahide Oki,Masahide Mori,Tomohito Kuwako, Koji Yamazaki,Atsuhisa Tamura,Masahiko Ando,Yasuhiro Koh

Cancer Researchno. 6_Supplement (2024): 964-964

引用0浏览0引用

Afatinib Plus Bevacizumab Combination after Osimertinib Resistance in Advanced EGFR-mutant Non-Small Cell Lung Cancer: Phase II ABCD-study

Akito Hata,Nobuyuki Katakami,Naoto Takase,Kayoko Kibata,Yuta Yamanaka,Motohiro Tamiya,Masahide Mori,Takashi Kijima,Satoshi Morita,Kazuko Sakai,Kazuto Nishio

LUNG CANCER（2024）

引用0浏览0WOS引用

A Randomized Phase II Trial of 8 Months of Afatinib Switching to Osimertinib (A) Versus Osimertinib Alone (B) As First-Line Treatment in Advanced NSCLC Patients with Common EGFR Mutation: YAMATO Study (TORG1939/WJOG12919L)

Atsushi Nakamura,Hiroshige Yoshioka, Toshihiro Misumi,Toshihide Yokoyama,Hidetoshi Itani,Motoko Tachihara,Kaoru Tanaka,Hiroaki Akamatsu,Akira Ono,Satoshi Ikeda,Takaaki Tokito,Yuki Sato,Masahide Mori,Takehiro Uemura,Akito Hata,Shinobu Hosokawa, Hideki Ishikawa,Nobuyuki Yamamoto,Hiroaki Okamoto,Takayasu Kurata

Journal of Clinical Oncologyno. 16_suppl (2024): 8574-8574

引用0浏览0引用

Comprehensive Serum Biomarker Analysis Reveals IL-8 Changes As the Only Predictor of the Effectiveness of Immune Checkpoint Inhibitors for Patients with Advanced Non-Small Cell Lung Cancer

Hiroaki Akamatsu,Yasuhiro Koh,Makoto Nishio,Yasushi Goto,Hidetoshi Hayashi,Satoru Miura,Koji Tamada,Hiroshi Kagamu,Akihiko Gemma,Ichiro Yoshino,Toshihiro Misumi, Atsuto Mouri,Ryota Saito,Naoto Takase,Noriko Yanagitani,Hiroshi Nokihara, Masahiro Seike,Kei Takamura,Masahide Mori,Shunichiro Iwasawa

Lung cancer (Amsterdam, Netherlands) (2024): 108017-108017

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn